ROCHESTER, N.Y., Dec. 9 — Carestream Health announced the U.S. Food and Drug Administration (FDA) has approved a Premarket Approval (PMA) supplement for enhanced screens and image processing software for its CR mammography system.
Carestream Health’s EHR-M3 screens are its third generation of screens designed specifically for mammography. The system has higher DQE (detective quantum efficiency) with the new screens, which were designed to enhance the quality of the acquired images. The latest approval also covers the application of Carestream Health’s advanced image processing algorithm that was designed to enhance the overall displayed quality of mammography images.
These features were released in other markets around the world earlier this year, and the latest approvals allow these advanced features to be immediately implemented in clinics, breast imaging centers and hospitals in the United States.
source: Carestream Health
12.20.2010
Carestream Health Announces FDA Approval Of Advanced Software, Screens For Its CR Mammography System
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment